Hopkins Janet Jill 4
4 · Aura Biosciences, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Aura Biosciences CMO Janet Hopkins Sells 20,401 Shares
What Happened
Janet Jill Hopkins, Chief Medical Officer of Aura Biosciences (AURA), sold 20,401 shares on 2026-02-17 in an automatic transaction to satisfy tax withholding tied to vesting restricted stock units. The weighted-average sale price was $5.06 per share, for total proceeds of approximately $103,229.
Key Details
- Transaction date: 2026-02-17; Form filed 2026-02-17 (timely).
- Transaction type/code: Sale (S) — open market/private sale; sale was automatic to cover tax withholding (footnote F1).
- Price details: reported weighted-average price $5.06; actual trades occurred across prices ranging $5.04–$5.31 (footnote F2).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing status: appears timely (no late filing noted).
Context
This sale was a tax-withholding event following RSU vesting and was automatic, not a discretionary sign of sentiment. Such withholding sales are common for executives and generally less informative than voluntary open-market purchases.
Insider Transaction Report
Form 4
Hopkins Janet Jill
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-17$5.06/sh−20,401$103,229→ 232,284 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Conor Kilroy, as Attorney-in-Fact|2026-02-17